1 Day MTNB -5.09% DJIA -0.03% Russell 2K -0.65% Health Care/Life Sciences 0.25% ...

After hours: March 19 at 7:46:19 p.m. EDT Loading Chart for MTNB ...

But the promise of AI in biopharma is equally tempered by the long journey ahead and the technology’s many uncertainties. For this year’s State of Tech in Biopharma report, we were deeply ...

Toronto, Ontario--(Newsfile Corp. - March 17, 2025) - At the request of the Canadian Investment Regulatory Organization, Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE ...

For example, 2024’s biopharma IPO market began promisingly with $3.6 billion in total funding in Q1 – the highest in several years – but fell to $1.6 billion across Q2 and Q3 combined ...

SAN FRANCISCO, CALIFORNIA, March 04, 2025 (GLOBE NEWSWIRE) -- GT Biopharma, Inc. (the “Company”) (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative ...

Alnylam jumps as expanded US approval for heart disease drug fuels growth prospects Alnylam Pharmaceuticals' shares rose more than 10% on Friday after the drugmaker secured U.S. approval for its ...

After hours: March 21 at 7:51:27 p.m. EDT Loading Chart for CRMD ...

The landscape of therapeutic development is being radically reshaped by rapid technological advancements. This event will provide a unique platform to explore how both established pharmaceutical ...

Researching and developing therapeutic products for human use.